Navigation Links
Dalai Lama, top scientists to discuss science & clinical applications of meditation

Conference addresses western medicine & society's embrace of meditation, press meeting with Dalai Lama, Hopkins Medical Dean Edward Miller, and Georgetown University Professor Aviad Haramati at 8am on Nov. 8

With Western medicine's increasing interest in meditation's affect on mental and physical well-being, the Mind & Life Institute, in partnership with the Georgetown University Medical Center, and the Johns Hopkins University School of Medicine will host "Mind & Life XIII: The Science and Clinical Applications of Meditation," November 8-10, 2005 at DAR Constitution Hall in Washington, DC. The historic conference on meditation, a convergence of Eastern and Western thinkers, will feature acclaimed speakers from scientific and contemplative communities, among them, His Holiness the Dalai Lama. A pre-event press meeting with the Dalai Lama, Johns Hopkins Medical Dean Edward Miller, and Georgetown University Professor Aviad Haramati will be held 8:00 - 9:00 am on Tuesday, November 8 on the "C" Street lobby level of DAR Constitution Hall.

The upcoming conference, on the cutting-edge of science and meditation, will be only the second public dialogue on this topic with the Dalai Lama, the internationally recognized Nobel laureate and Tibetan spiritual leader. In 2003, the McGovern Institute for Brain Research at MIT co-sponsored the first public conference on how the mind works, involving Buddhist leaders, including the Dalai Lama, and neuroscientists. That meeting received international media coverage and was included in a cover story on meditation in TIME Magazine.The Mind & Life conference offers science and medical professionals a rare opportunity to learn about the intersection of meditation and medicine. The conference, which will be held in dialogue format, will feature sessions on meditation-based clinical interventions: science, practice, and implementation, possible biological substrates of meditation, clinical research on meditati
'"/>

Source:Mind and Life Institute


Page: 1 2 3

Related biology news :

1. Wisconsin scientists grow critical nerve cells
2. UCSB scientists probe sea floor venting to gain understanding of early life on Earth
3. UAB scientists discover the origin of a mysterious physical force
4. Fox Chase Cancer Center scientists identify immune-system mutation
5. Weizmann Institute scientists develop a new approach for directing treatment to metastasized prostate cancer in the bones.
6. U-M scientists find genes that control growth of common skin cancer
7. UCLA scientists transform HIV into cancer-seeking missile
8. RNA project to create language for scientists worldwide
9. Carnegie Mellon scientists develop tool that uses MRI to visualize gene expression in living animals
10. To control germs, scientists deploy tiny agents provocateurs
11. Leprosy microbes lead scientists to immune discovery

Post Your Comments:
(Date:11/24/2009)... Stents that keep weakened and flabby arteries fr...r six months, those stents are no longer needed --...nnecessary. Previously, doctors had no choice but ... of Tel Aviv University,s Department of Biomedical...ber platform that carries drugs where they,re need...
(Date:11/24/2009)... Springer and the American College of Medical Tox...rate on the publication of the Journal of Medical...MT, beginning in March 2010. It was previously pu..., The Journal of Medical Toxicology , an intern...vancing the science and practice of medical toxico...
(Date:11/24/2009)..., BATON ROUGE Antarctica has long held secrets ...nd until recently, there has been very little info...beneath miles of ice for millions of years. Now, a...ding LSU have been funded to the tune of $10 mill... NSF, to get to the bottom of things literally. T...
Breaking Biology News(10 mins):A coating for life 2Springer and the American College of Medical Toxicology to work together 2LSU gets to the bottom of things -- in Antarctica 2Endologix Announces Live Web Cast of Presentation in SMH Capital Small Cap Spotlight on June 17 2009 at 4 3A15 p m ET 48957 1Endologix Announces Live Web Cast of Presentation in SMH Capital Small Cap Spotlight on June 17 2009 at 4 3A15 p m ET 48957 2Psoriasis Raises Risk of Heart Attack Stroke Death 48954 1Psoriasis Raises Risk of Heart Attack Stroke Death 48954 2MUHC researcher awarded 24500 000 to study pathogenesis of infectious disease 48951 1MUHC researcher awarded 24500 000 to study pathogenesis of infectious disease 48951 2
... that moonlight, having different roles at differe... being killed. The moonlighting activity of one en...ially resistant to a family of broad-spectrum anti...tember issue of the journal Microbiology. , "G...eria use to make the building blocks of cell walls...
...y recent reports documenting the therapeutic effic...odels of human disease may actually be describing ...ility of siRNA to activate an immune response, acc...ume 19, Number 9) of Human Gene Therapy , a peer-...c. The paper, which was published "instant online,...
...ncerned about the toll that mental health disorder...l have a unique opportunity to hear from world-cla...es, symptoms and progression of such illnesses as ...ia and autism, and learn about current and potenti... Healthy Minds Across America, 48 free public foru...
Other Biology News:Energy-saving bacteria resist antibiotics 2Previous claims of siRNA therapeutic effects called into question by report in human gene therapy 2Healthy Minds Across America features 48 public forums on mental health research, Sept. 14 2Healthy Minds Across America features 48 public forums on mental health research, Sept. 14 3
(Date:11/24/2009)...eenmetforpatientswithadvanced-stage,orrecurrentend...e-FirstCall/-AEternaZentarisInc.(NASDAQ: AEZS ;TSX...yfocusedonendocrinetherapyandoncology,todayannounc...tedcytotoxicpeptideconjugate,AEZS-108(formerlyAN-1...ncer.Inapersonalizedhealthcareapproach,thestudysel...
(Date:11/24/2009)...e-FirstCall/--Shireplc(LSE:SHP,NASDAQ: SHPGY ),th...ouncedthatithassubmittedaMAAtotheEuropeanMedicines...acementtherapyindevelopment,forthetreatmentofType1...forvelaglucerasealfathathasbeensubmitted,withprevi...Basedonaglobalsupplyshortageofthecurrentlyapproved...
(Date:11/24/2009)...RNewswire-FirstCall/--GenomicHealth,Inc.(Nasdaq: G...xecutiveChairman,willpresentatthe21stAnnualPiperJa...cember1,2009at10:00a.m.ET. ,, Toaccessthelivean...ttheInvestorRelationssectionofGenomicHealth,swebsi...ecttothewebsiteatleast15minutespriortothebeginning...
(Date:11/24/2009)...onnects Customers with Partners Validated to Proce...Products , Ottawa, ON (PR... provider of products for biological sample collec...ed its new global partner program. The program off...tner community and is designed to help partners sc...
Breaking Biology Technology:AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Genomic Health to Present at Piper Jaffray Health Care Conference 2DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3
...ented at the AACR,meeting in San Diego efficacy an... for ovarian cancer. FAS31 is an inhibitor of fatt...xpressed in many human cancers. Numerous,studies h...ytotoxic to a,variety of human xenograft models wi...AS31 showed no observable toxicity in normal tissu...
...asdaq:,EVVV) will release its 2008 first quarter f...gular market trading hours., The company will hos...30 a.m. CT (8:30 a.m. ET). ev3 management will rev... outlook, followed by a question and answer,sessio...rested parties through a,live audio webcast at ht...
...BCI), a,biopharmaceutical company utilizing its pl...s that promote the growth of new neurons for the t... announced today that it raised an,additional $20 ... bringing,the total to $50 million. New investor, ... investors and Alexandria Real Estate Equities, In...
Other Biology Technology:FASgen, Inc. Presents Ovarian Cancer Efficacy and Toxicology Data to the American Association for Cancer Research 2REVISED: BrainCells Inc. Expands Series B Financing to $50 Million 2
Mouse Anti-Human RDH5 Polyclonal Antibody, Unconjugated from Abnova Corporation
...Lines ,High Quality, Functionally-Validated, Ion C...or having a critical role in nerve and muscle func... CNS and the heart. Drugs that modulate ion channe...ch as neuropathic pain, cardiac arrhythmia, hypert...
The Discovery Series PDQuest Version Upgrade from Bio-Rad
Mouse Anti-Human ARHGEF11 Monoclonal Antibody, Unconjugated, Clone 2F4 from Abnova Corporation
Biology Products: